-
Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death (Wild Type Midmyocardial Cell)
-
Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death
Located in
Exposures
/
Clancy, Rudy, 2001
-
Mechanisms of Abnormal Calcium Homeostasis in Mutations Responsible for Catecholaminergic Polymorphic Ventricular Tachycardia
-
Mechanisms of Abnormal Calcium Homeostasis in Mutations Responsible for Catecholaminergic Polymorphic Ventricular Tachycardia
Located in
Exposures
/
Iyer, Hajjar, Armoundas, 2007
-
Ionic mechanism of electrical alternans
-
Ionic mechanism of electrical alternans
Located in
Exposures
/
Fox, McHarg, Gilmour, 2002
-
A model for human ventricular tissue
-
A model for human ventricular tissue
Located in
Exposures
/
Ten Tusscher, Noble, Noble, Panfilov, 2004
-
A model for human ventricular tissue
-
A model for human ventricular tissue
Located in
Exposures
/
Ten Tusscher, Noble, Noble, Panfilov, 2004
-
A model for human ventricular tissue
-
A model for human ventricular tissue
Located in
Exposures
/
Ten Tusscher, Noble, Noble, Panfilov, 2004
-
Model study of ATP and ADP buffering, transport of Ca2+ and Mg2+, and regulation of ion pumps in ventricular myocyte
-
Model study of ATP and ADP buffering, transport of Ca2+ and Mg2+, and regulation of ion pumps in ventricular myocyte
Located in
Exposures
/
Michailova, McCulloch, 2001
-
An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis
-
An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis
Located in
Exposures
/
Gupta, Maurya, Stephens, Dennis, Subramaniam, 2009
-
A pharmacodynamic model for the time course of tumor shrinkage by gemcitabine + carboplatin in non-small cell lung cancer patients
-
A pharmacodynamic model for the time course of tumor shrinkage by gemcitabine + carboplatin in non-small cell lung cancer patients
Located in
Exposures
/
Tham, Wang, Soo, Lee, Lee, Yong, Goh, Holford, 2008
-
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
-
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
Located in
Exposures
/
Bonhoeffer, Rembiszewski, Ortiz, Nixon, 2000
